Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |